¥1.15 billion borrowing in preparation for COVID-19
First written in FY2020. 2 of 4 entries say "Restated". Latest entry: FY2022.
22 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「Cash flows from financing activities amounted to ¥586 million, due mainly to proceeds of ¥1,150 million from long-term borrowings and other factors. This represented an increase of ¥1,057 million from the same period of the previous year.」
The execution of total long-term borrowings of ¥1,150 million in preparation for COVID-19 was confirmed for the full fiscal year as well. - FY2021RestatedAnnual report
「Cash flows from financing activities amounted to ¥586 million, due mainly to dividend payments of ¥203 million and proceeds of ¥1,150 million from long-term borrowings. This represented an increase of ¥1,057 million from the same period of the previous year.」
The execution of total long-term borrowings of ¥1,150 million in preparation for COVID-19 was confirmed for the full fiscal year as well. - FY2021-Q2AdvancedAnnual report
「Cash flows from financing activities amounted to ¥758 million, despite dividend payments of ¥203 million, due mainly to proceeds of ¥1,150 million from long-term borrowings. This represented an increase of ¥1,093 million from the same period of the previous year.」
The agreement to borrow a total of ¥1,150 million in preparation for COVID-19 was executed, with ¥1,150 million in proceeds from long-term borrowings recorded in the first half. - FY2020First statedAnnual report
「The Group agreed to borrow funds from its relationship financial institutions as follows. (1) Purpose of funds: Funds to prepare for unforeseen circumstances caused by the impact of COVID-19 (3) Borrowing amount: ¥1,150 million (5) Drawdown dates: 31 March 2020, 29 May 2020, and scheduled for July 2020 (6) Repayment period: 30 June 2020 to 31 July 2030」
The Company disclosed its agreement to borrow a total of ¥1,150 million from its relationship financial institutions to prepare for unforeseen circumstances caused by COVID-19.